GlassScriptPhysician profile
Brian Adrian Cornwell
NPI 1518515824
$5,866.35
in general payments reported to CMS, 2019-2025
15 companies · $406 in 2025
The $406 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $137 · 2022: $1,999 · 2023: $2,832 · 2024: $493 · 2025: $406.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,369 · Travel and Lodging: $1,330 · Education: $31.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,368.84 |
| Travel and Lodging | $1,330.36 |
| Education | $31.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,656.76 | 2021-2025 | General - Therapies, Latitude Communicator Power Supply, Watchman Flx |
| Medtronic, INC. | $1,959.43 | 2021-2025 | Attain Command + Surevalve, Omniasecure Mri Surescan, Corevalve Evolut R |
| Biosense Webster, INC. | $338.19 | 2022-2024 | Carto 3 |
| E.R. Squibb & Sons, L.L.C. | $306.08 | 2022-2023 | Eliquis, Camzyos |
| Novartis Pharmaceuticals Corporation | $194.65 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $85.71 | 2022-2023 | Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $73.04 | 2022-2025 | Jardiance |
| Novo Nordisk INC | $51.64 | 2024 | Wegovy, Ozempic |
| Inspire Medical Systems, INC. | $39.62 | 2025 | Inspire |
| Abiomed | $36.45 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $34.88 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $30.89 | 2022-2024 | Verquvo |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $29.50 | 2024-2025 | Lifevest |
| Pfizer INC. | $16.03 | 2023 | |
| Tactile Systems Technology INC | $13.48 | 2023 | Entre Plus, Flexitouch Plus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Cornwell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.